regulatory inspection pharma – Pharma GMP

How to Respond to EMA GMP Inspection Findings

digi — Mon, 08 Sep 2025 06:01:37 +0000

How to Respond to EMA GMP Inspection Findings Effective Strategies for Responding to EMA GMP Inspection Findings Introduction: Why This Topic Matters for GMP Compliance The European Medicines Agency (EMA), through its network of inspectors from EU member states, conducts Good Manufacturing Practice (GMP) inspections to ensure medicines meet quality and safety requirements. When deficiencies...

Case Study: A GMP Failure That Cost $1 Billion in Recalls

digi — Sun, 07 Sep 2025 12:25:41 +0000

Case Study: A GMP Failure That Cost $1 Billion in Recalls Case Study: A $1 Billion Pharma Recall Caused by GMP Failures Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical recalls not only represent a financial loss but also carry severe implications for patient safety and public trust. Among the most high-profile cases in...

Cross-Contamination Control: GMP Rules You Can’t Ignore

digi — Sat, 06 Sep 2025 21:06:50 +0000

Cross-Contamination Control: GMP Rules You Can’t Ignore Essential GMP Rules for Preventing Cross-Contamination in Pharma Introduction: Why This Topic Matters for GMP Compliance Cross-contamination in pharmaceutical manufacturing poses one of the most serious risks to patient safety and product quality. Regulatory agencies such as the FDA, EMA, WHO, and PIC/S consistently identify contamination control failures...

How to Handle a 483 Observation Without Panic

digi — Thu, 04 Sep 2025 22:11:34 +0000

How to Handle a 483 Observation Without Panic Effective Strategies to Handle FDA 483 Observations Calmly and Confidently Introduction: Why This Topic Matters for GMP Compliance During FDA inspections, investigators document potential violations of current Good Manufacturing Practice (cGMP) on Form 483. Receiving a 483 can be stressful for pharmaceutical manufacturers, but it is not...

Common GMP Issues in Tablet Manufacturing

digi — Thu, 04 Sep 2025 12:50:38 +0000

Common GMP Issues in Tablet Manufacturing Frequent GMP Challenges in Tablet Manufacturing and How to Address Them Introduction: Why This Topic Matters for GMP Compliance Tablet manufacturing, as a major component of oral solid dosage (OSD) production, is subject to strict regulatory oversight. Global agencies such as the FDA, EMA, and WHO closely examine GMP...

Preparing for a Surprise FDA Inspection: Complete SOP

digi — Thu, 04 Sep 2025 04:07:32 +0000

Preparing for a Surprise FDA Inspection: Complete SOP Comprehensive SOP for Handling Surprise FDA Inspections Introduction: Why This Topic Matters for GMP Compliance FDA inspections are designed to ensure that pharmaceutical manufacturers consistently comply with Good Manufacturing Practices (GMP). While some inspections are pre-announced, many are unannounced or “surprise” inspections. These inspections test a company’s...